Baxter International Inc. (BAX) is listed on NYSE in Medical Device Stocks. It is $26.13, +0.77%, with a $13.5B market cap. RSI is 58.4, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 58.4 Neutral
Market Cap $13.5B
Volume 2.8M
Fundamentals — 10-Q Q2 2026
Revenue $5.7B
Net Income $111.0M
EPS $0.21
Gross Margin 34.0%
Operating Margin 5.0%
Net Margin 2.0%
P/E Ratio 124.4x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Mason Jeanne K | EVP, Chief HR Officer | Sell | 64,488 | $40.61 | $2.6M | 2024 Mar 1 |
| Stroucken Albert P L | Director | Sell | 3,930 | $37.52 | $147,454 | 2023 Mar 20 |
| Kunzler Jacqueline | SVP, Chief Quality Officer | Sell | 3,813 | $40.50 | $154,427 | 2023 Feb 21 |
| Mason Jeanne K | SVP, Human Resources | Sell | 59,477 | $44.70 | $2.7M | 2023 Jan 17 |
| Stroucken Albert P L | Director | Sell | 4,020 | $76.02 | $305,612 | 2022 Apr 5 |
| Hellman Peter S | Director | Sell | 4,020 | $76.02 | $305,593 | 2022 Apr 5 |
| Forsyth John D | Director | Sell | 1,005 | $77.68 | $78,068 | 2022 Apr 1 |
| Forsyth John D | Director | Sell | 1,005 | $84.82 | $85,244 | 2022 Mar 1 |
| Stevens Brian | SVP, CAO and Controller | Sell | 2,500 | $85.50 | $213,757 | 2022 Feb 28 |
| Mason Jeanne K | SVP, Human Resources | Sell | 54,143 | $85.02 | $4.6M | 2022 Feb 14 |
| Chen Thomas F | Director | Sell | 1,680 | $84.53 | $142,010 | 2022 Feb 2 |
| Forsyth John D | Director | Sell | 1,005 | $85.59 | $86,018 | 2022 Feb 1 |
| Martin Sean | SVP and General Counsel | Sell | 21,450 | $79.57 | $1.7M | 2021 Nov 1 |
| Martin Sean | SVP and General Counsel | Sell | 19,800 | $77.26 | $1.5M | 2021 Aug 2 |
| Frye Andrew | SVP, President, APAC | Sell | 10,999 | $84.79 | $932,605 | 2021 Apr 12 |
| Stroucken Albert P L | Director | Sell | 4,990 | $84.56 | $421,954 | 2021 Apr 5 |
| Hellman Peter S | Director | Sell | 4,990 | $84.56 | $421,954 | 2021 Apr 5 |
| Martin Sean | SVP and General Counsel | Sell | 47,001 | $78.67 | $3.7M | 2020 Nov 2 |
| Forsyth John D | Director | Sell | 310 | $83.59 | $25,913 | 2020 Sep 14 |
| Gavin James R III | Director | Sell | 14,899 | $86.41 | $1.3M | 2020 Aug 3 |
Other Medical Device Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $46.83 | 45.9 | $67.9B |
| | $330.77 | 51.3 | $126.9B |
| | $91.21 | 57.7 | $116.7B |
| | $71.19 | 38.1 | $13.9B |
| | $336.97 | 36.7 | $23.7B |
| | $179.79 | 57.4 | $10.6B |
| | $233.75 | 57.8 | $22.8B |
Take BAX further
- Browse Medical Device Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put BAX in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Baxter International Inc. next reports.
Set alerts on BAX
Get notified when Baxter International Inc. hits your price targets or technical conditions are met.
Get Started Free